Kensington Investment Counsel, LLC Repligen Corp Transaction History

Kensington Investment Counsel, LLC

$218 Million
Q1 2024

A detailed history of Kensington Investment Counsel, LLC transactions in Repligen Corp stock. As of the latest transaction made, Kensington Investment Counsel, LLC holds 9,823 shares of RGEN stock, worth $1.18 Million. This represents 0.83% of its overall portfolio holdings.

Number of Shares

9,823

Previous 7,708 27.44%

Holding current value

$1.18 Million

Previous $1.39 Million 30.4%

% of portfolio

0.83%

Previous 0.73%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$170.78 - $208.42 $361,199 - $440,808	2,115 Added 27.44%	9,823 $1.81 Million
Q4 2023 Feb 15, 2024	SELL	$114.17 - $185.35 $2,511 - $4,077	-22 Reduced 0.28%	7,708 $1.39 Million
Q3 2023 Nov 09, 2023	BUY	$138.78 - $176.51 $43,299 - $55,071	312 Added 4.21%	7,730 $1.23 Million
Q2 2023 Aug 14, 2023	SELL	$138.42 - $180.31 $16,887 - $21,997	-122 Reduced 1.62%	7,418 $1.05 Million
Q1 2023 May 11, 2023	SELL	$154.26 - $198.1 $273,502 - $351,231	-1,773 Reduced 19.04%	7,540 $1.27 Million

Q3 2022 Nov 14, 2022	BUY	$160.42 - $256.21 $6,256 - $9,992	39 Added 0.42%	9,313 $1.74 Million
Q2 2022 Jul 15, 2022	BUY	$140.68 - $188.02 $619,273 - $827,664	4,402 Added 90.35%	9,274 $1.51 Million
Q1 2022 May 16, 2022	BUY	$161.19 - $257.96 $785,317 - $1.26 Million	4,872 New	4,872 $916,000
Q1 2022 May 13, 2022	SELL	$161.19 - $257.96 $1.39 Million - $2.22 Million	-8,613 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$247.59 - $304.47 $243,876 - $299,902	985 Added 12.91%	8,613 $2.28 Million
Q2 2021 Aug 13, 2021	BUY	$165.87 - $220.95 $29,358 - $39,108	177 Added 2.38%	7,628 $1.52 Million
Q1 2021 May 13, 2021	BUY	$180.37 - $226.26 $83,511 - $104,758	463 Added 6.63%	7,451 $1.45 Million
Q4 2020 Feb 16, 2021	BUY	$148.08 - $206.57 $1.03 Million - $1.44 Million	6,988 New	6,988 $1.34 Million

Others Institutions Holding RGEN

# of Institutions

522

Shares Held

53.2M

Call Options Held

1.05M

Put Options Held

228K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.67B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kensington Investment Counsel, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kensington Investment Counsel, LLC with notifications on news.

Account

Kensington Investment Counsel, LLC Repligen Corp Transaction History